DiaGenic – Gene Expression Diagnostics

International media relations and marketing communications since January 2005

The Client brief: To raise the international profile of this gene expression specialist in order to attract licensing partners among the leading diagnostic companies

What we do: To coincide with research published in the journal Breast Cancer Research, Amanda and Richard devised and implemented a major international press campaign in the professional and consumer media.

This resulted in extensive coverage including national press, women’s and consumer health titles and Sky TV. We worked with our Boston, Massachusetts-based partner, Schwarz Communications, to achieve similar coverage in the United States. Since DiaGenic is listed on the Oslo Stock Exchange, this work involved careful coordination with the company's Investor Relations team.
A similar strategy will be adopted as DiaGenic’s technology is applied to other disease areas.

Download press clipping